Insights Into Non-small Cell Lung Cancer (NSCLC) 2024
Perspectives of community physicians from across the US on the drivers in treatment decisions in the management of lung cancer
Puerto Rico – September 3, 2024
Faculty Chair
Martin Dietrich, MD, PhD
University of Central Florida, Orlando, FL, USA
Atlanta – October 12, 2024
Faculty Chair
Martin Dietrich, MD, PhD
University of Central Florida, Orlando, FL, USA
Orlando – October 19, 2024
Faculty Chair
Martin Dietrich, MD, PhD
University of Central Florida, Orlando, FL, USA
DC – November 2, 2024
Faculty Chair
Joshua Sabari, MD
NYU Langone Health, New York, NY, USA
Denver – November 9, 2024
Faculty Chair
Martin Dietrich, MD, PhD
University of Central Florida, Orlando, FL, USA
More Information
- Virtual
- Puerto Rico
More Information
- Virtual
- Georgia
More Information
- Orlando
- Florida
More Information
- DC
- Virginia, Maryland
More Information
- Denver
- Arizona, Colorado, Nebraska, Texas
REPORT SNAPSHOT
- A moderated roundtable discussion focusing on the management and current use of treatment options for EGFR-mutant NSCLC in the community setting
- Disease state and data presentations were developed in conjunction with a national or regional oncology expert
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- Data collection was accomplished through use of audience response system questioning and moderated discussion
- The group of advisors comprised 10–15 medical oncologists representative of each region
